Foundation Medicine Announces 2016 Third Quarter Results and Recent Highlights
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Needham Starts NeoVolta (NEOV) at Buy
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
Genentech (RHHBY) to Make 60+ Presentations at ASH 2016; Will Include Phase III GALLIUM Study Data
November 3, 2016 12:39 PM EDTGenentech, a member of the Roche Group (OTC: RHHBY), announced that more than 60 abstracts featuring nine of its approved or investigational medicines will be presented during the 58th American Society of Hematology (ASH) Annual Meeting from December 3-6 in San Diego. The abstracts include more than 20 oral presentations across a broad range of medicines and combinations.
The breadth of data we are presenting at ASH this year reflects our deep commitment to people with blood diseases, said Sandra Horning, M.D., chief medical officer and head of Global Product Development. We are... More
Benchmark Downgrades Foundation Medicine (FMI) to Hold
November 3, 2016 7:35 AM EDTBenchmark downgraded Foundation Medicine (NASDAQ: FMI) from Buy to Hold.
For an analyst ratings summary and ratings history on Foundation Medicine click here. For more ratings news on Foundation Medicine click here.
Shares of Foundation Medicine closed at $21.40 yesterday.
... More